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Abstract Studies with detergent:lipid mixed micelles reveal 
that diacylglycerol directly stimulates the intrinsic tyrosine ki- 
nase activity of the insulin receptor. Kinetic analyses indicate that 
diacylglycerol activates the kinase by causing a marked increase 
in the affinity of the receptor for insulin. In contrast, diacylglyc- 
erol has no effect on the insulin receptor's catalytic activity or its 
affinity for ATP. Stimulation of the insulin receptor is not a result 
of protein kinase C activation. First, phorbol myristate acetate, 
a potent activator of protein kinase C, has no effect on insulin 
receptor activity. Second, the activation by diacylglycerol is not 
stereospecific, in marked contrast o the specificity for 1,2-diacyl- 
sn-glycerol in the activation of protein kinase C. Because circulat- 
ing levels of insulin are below the/Ca of the insulin receptor for 
insulin, the ability of diacylglycerol to modulate the affinity of the 
receptor for ligand suggests that increases in cellular levels of 
diacylglycerol directly sensitize the receptor to insulin. 
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1. Introduction 
Diacylglycerol is produced in response to the plethora of 
signals that activate phospholipase Cs. Such signals are now 
known to be processed both by G protein-coupled receptors [1 ], 
as originally discovered, and by receptor tyrosine kinases [2]. 
The former receptors couple to G proteins that activate mem- 
bers of the phospholipase Cfl family, whereas the latter recep- 
tors mediate activation of members of the phospholipase Cy 
family via SH2 and SH3 domains [3]. Diacylglycerol is also 
produced by activation of phospholipase D to yield phosphat- 
idic acid and then diacylglycerol [1]. The primary target of 
diacylglycerol is protein kinase C, a family of lipid-regulated 
enzymes that is allosterically regulated by diacylglycerol and 
phosphatidylserine [4,5]. Mounting evidence suggests that 
other proteins may also be sensitive to diacylglycerol. For ex- 
ample, the respiratory burst enzyme, NADPH oxidase, is stim- 
ulated by diacylglycerol and phosphatidic acid [6]. In addition, 
the activities of phospholipase A 2 [7,8] and CTP:phospho- 
choline cytidylyltransferase [9] are modulated by diacylglycerol. 
The production of diacylglycerol in response to receptor 
tyrosine kinase activation led us to explore whether the insulin 
receptor may be regulated by diacylglycerol. This heterotetra- 
meric protein comprises two extracellular ~subunits disulfide- 
linked to two transmembrane fl subunits [10]. Insulin binding 
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promotes autophosphorylation, which activates the enzyme to- 
wards substrate phosphorylation. The activated receptor ki- 
nase phosphorylates its primary substrate, IRS-1, on YMXM 
motifs, thus converting IRS-1 into a docking protein for SH2 
domain-containing proteins uch as phosphatidylinositol 3-ki- 
nase or Grb2 [11]. Insulin stimulation has been reported to 
cause diacylglycerol levels to increase in several cell types 
[12,13]. The possibility that this increase is mediated by phos- 
pholipase Cy is suggested by the finding that insulin stimulates 
the activity of this enzyme in plasma membrane preparations 
[14]. Insulin-stimulated increases in diacylglycerol concentra- 
tions have also been reported to result from de novo synthesis 
[12,13], from cleavage of a novel phosphatidylinositol glycan 
[15,16], and from cleavage of phosphatidylcholine [17]. 
Here we show that the lipid second messenger, diacylglyc- 
erol, directly stimulates the tyrosine kinase activity of the insu- 
lin receptor by increasing its affinity for insulin. Thus, genera- 
tion of diacylglycerol in the plasma membrane may up-regulate 
insulin receptor activity by sensitizing the receptor to insulin. 
2. Materials and methods 
2.1. Materials 
ATE bovine serum albumin (BSA), 5-bromo-4-chloroindoyl phos- 
phate, 1,2-dioleoyl-sn-glycerol, enzyme-free cell dissociation solution, 
HEPES, leupeptin, phorbol myristate acetate, and phenylmethylsul- 
fonyl fluoride (PMSF) were purchased from Sigma Chemical Com- 
pany. 2,3-Dioleoyl-sn-glycerol was a generous gift from Dr. David 
Daleke. 1,3-Dioleoybsn-glycerol was purchased from Nu Chek Prep. 
All phospholipids were purchased from Avanti Polar Lipids. Alkaline 
phosphatase-conjugated goatanti-mouse IgG and peroxidase-conju- 
gated goat anti-mouse IgG were supplied by Boehringer Mannheim 
Biochemicals and anti-phosphotyrosine a tibody (PY20) was obtained 
from ICN Biomedicals, Inc. ~25I-labelled anti-mouse IgG was from 
Amersham and Renaissance Western blot chemiluminescence reagent 
was obtained from Dupont. Porcine insulin was purchased from Calbi- 
ochem and Triton X-100 (10% aqueous olution low in carbonyl and 
peroxide content) was supplied by Pierce Chemical Company. Nitrocel- 
lulose membranes were obtained from Schleicher and Schuell. Protein 
kinase C fill was purified to homogeneity from a baculovirus expres- 
sion system, as described [18]. All other chemicals were reagent grade. 
2.2. Methods 
2.2.1. Insulin receptor. NIH 3T3 HIR 3.5 cells, which express on 
the order of 106 copies of the human insulin receptor per cell [19], served 
as the source of insulin receptor. Cells (approximately 5 x 106) were 
harvested in 10 ml enzyme-free cell dissociation solution, pelleted by 
centrifugation at 1300 x g for 1 rain at room temperature, then lysed 
in 4 ml solution containing 50 mM HEPES (pH 7.5), 1 mM EDTA and 
1 mM PMSF. The lysate was centrifuged at 540,000 x g for 10 min, 
4°C, and the particulate fraction was resuspended in 50 mM HEPES 
(pH 7.5), 0.1% Triton X-100, and gently homogenized to solubilize 
membrane proteins. The solution was then centrifuged for 10 min at 
630,000 x g, 4°C, to remove detergent-insoluble material. The superna- 
rant, containing detergent-solubilized membrane proteins, was col- 
lected and used immediately for assays. Concentrations of endogenous 
lipid and protein in the detergent-soluble fraction were approximately 
1 mM and 1 mg'ml -~, respectively. Insulin receptor partially purified 
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from rat liver by wheat germ agglutinin chromatography [20] was used 
in some assays. 
2.2.2. Lipids. Lipids in chloroform solution were dried under a 
stream of N2 and hydrated in 50 mM HEPES (pH 7.5) containing 0.1% 
Triton X-100 [20]. Lipid:detergent mixtures, containing 04  mM lipid, 
were diluted into an assay mix containing 0.1% Triton X-100 to yield 
a final detergent concentration of 0.1% and final lipid concentrations 
of 0-0.5 mM. 
2.2.3. Insulin receptor assay. The detergent-solubilized fraction 
from NIH 3T3 HIR 3.5 cells (10 pl) was added to lipid:detergent 
mixtures (20 pl, 0-1.8 mM lipid and 0.1% Triton X-100) and vortexed. 
A solution (27/11) containing 2.6 mM DTT, and 0 or 26 J~M insulin in 
50 mM HEPES (pH 7.5), 0.07% Triton X-100 was added and allowed 
to incubate for 5 min at 21°C or 13.5°C. Autophosphorylation was 
initiated by the addition of 14 pl of a solution containing 50 mM 
HEPES, 25 mM MnC12, 20 mM MgC12, 0.15% Triton X-100, and 250 
/IM ATP at 21 °C or 13.5°C. The final concentrations of the species in 
reaction mixture were 10 nM insulin, 1 mM DTT, 0-0.5 mM lipid, 
5 mM MnC12, 4 mM MgCI2, 50pM ATE 0.1% Triton X-100, 50 mM 
HEPES (pH 7.5). The reaction was stopped after 2 min, unless other- 
wise indicated, by the addition of a quarter volume of SDS-poly- 
acrylamide electrophoresis ample buffer (0.13 M Tris, 4.2% SDS, 21% 
glycerol, 0.004% bromophenol b ue, 20% fl-mercaptoethanol, pH 6.8). 
In some experiments, receptor sample was mixed with lipid and DTT, 
and then incubated with increasing concentrations of insulin (0 700 
nM). In one experiment the ATP concentration was varied from 0 to 
100 pM. Samples were analyzed by SDS-polyacrylamide g l electro- 
phoresis (7.5% acrylamide) followed by electrophoretic ransfer of pro- 
teins to nitrocellulose membranes. Phosphotyrosine-labelled proteins 
were detected by Western blot analysis using primary antibodies pe- 
cific for phosphotyrosine r sidues and secondary antibodies labelled 
with '251 or coupled to alkaline phosphatase or peroxidase. Primary 
antibody labelling was detected by monitoring the formation of the 
insoluble product of 5-bromo-4-chloroindoyl phosphate hydrolysis 
[21], chemiluminescence, or autoradiography. Blots (chemiluminescent 
and ~25I-labelled) or photographic negatives of blots (stained by alkaline 
phosphatase reaction), were analyzed with a Molecular Dynamics 
Computing Densitometer or Phosphorimager; relative labelling of 
phosphotyrosine was quantified by integrating the area around the fl 
subunit using the ImageQuant software. Analysis by all methods 
yielded qualitatively similar results. 
2.2.4. Protein kinase C assay. The activity of protein kinase C to- 
wards phospborylation fa peptide substrate [22] was measured in the 
presence of Ca 2+ (1.2 mM) and Triton X-100 (0.1%) mixed micelles 
containing 15 mol% phosphatidylserine and 5 tool% either 1,2-dioleoyl- 
sn-glycerol, 1,3-dioleoyl-sn-glycerol, r 2,3-dioleoyl-sn-glycerol, as de- 
scribed [18]. 
3. Results and discussion 
3.1. Diacylglycerol increases insulin receptor tyrosine kinase 
activity 
The effect of diacylglycerol on the activity of human insulin 
receptor was measured by incubation of Triton X-100-solubil- 
ized membranes from N IH  3T3 H IR  3.5 cells with increas- 
ing concentrations of diacylglycerol 1. Fig. 1 shows that di- 
oleoylglycerol caused a 2.3-fold increase in the amount of 
phosphotyrosine associated with the fl subunit of the receptor 
after 2 min incubation with ATE Half-maximal stimulation 
was elicited by approximately 100 pM diacylglycerol, corre- 
sponding to 6 mol%. In contrast o its effects on insulin-stimu- 
lated activity, diacylglycerol had no significant effect on auto- 
phosphorylation i the absence of insulin. Autophosphoryla- 
'Assays contained 100 ,uM endogenous lipid (corresponding to 6 
mol%), 0.1% Triton X-100 (corresponding to approximately 10 pM 
micelles based on an aggregation number of 140 at 25°C [24], 0-500/tM 
diacylglycerol, and approximately 100 gtg.ml -~ (approximately 1/IM) 
protein. Thus, the ratio of micelles to total protein was on the order of 
10:1. 
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Fig. 1. Diacylglycerol stimulates insulin receptor autophosphorylation. 
Detergent-solubilized NIH 3T3 HIR 3.5 cell membranes were incu- 
bated in the presence of 0.1% Triton X-100 mixed micelles containing 
0-500 pM (0-26 tool%) 1,2-dioleoyl-sn-glycerol and 50/IM ATP in the 
absence (e) or presence (©) of 10 nM insulin for 2 min at 21°C. Samples 
were analyzed by Western blot analysis and tyrosine phosphorylation 
of the fl subunit detected by labelling with phosphotyrosine antibodies, 
as described in section 2. Data are presented as the intensity of 
phosphotyrosine staining relative to samples not incubated with dia- 
cylglycerol. Error bars represent the standard error of the mean for 
three sets of data. Inset: Western blot of samples probed with 
phosphotyrosine antibodies and detected with chemiluminescence, 
showing increasing tyrosine phosphorylation f the fl subunit (95 kDa) 
of the insulin receptor with increasing diacylglycerol (DG) concentra- 
tions. 
tion measured in the presence of a constant amount of dia- 
cylglycerol but increasing amounts of Triton X-100 revealed 
that stimulation was dependent on the mole fraction of dia- 
cylglycerol, rather than the absolute concentration of lipid (not 
shown). Protein kinase C is similarly dependent on the relative 
concentration of lipid in Triton X-100 mixed micelles [23]. 
Qualitatively similar results were obtained with insulin receptor 
partially purified from rat liver (not shown), indicating that 
membrane proteins present in the assay mixture were not in- 
volved in the diacylglycerol-mediated stimulation. 
3.2. Diaeylglycerol &creases the affinity of the &sulin receptor 
for insulin 
To explore how diacylglycerol stimulates the insulin recep- 
tor, the effect of this lipid on kinetic parameters for regulation 
by insulin and ATP were examined. Table 1 shows that 250/~M 
dioleoylglycerol (15 mol%) decreased the ECs0 for insulin 4-fold 
but had no significant effect on Vma x. Dioleoylglycerol had no 
significant effect on the K m or  Vma x for ATE either at sub-satu- 
rating (10 nM) or saturating (700 nM) insulin concentrations. 
Thus, diacylglycerol stimulates the insulin receptor by increas- 
ing its affinity for insulin rather than by affecting catalysis. 
One possible explanation for the diacylglycerol-mediated in- 
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Table 1 
Effect of diacylglycerol on the insulin receptor's affinity for insulin or ATP 
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Insulin ATP 
50 ,uM ATP 10 nM insulin 700 nM insulin 
EC5o (nM) Vm~  Km (tiM) Vm~ x K m (pM) Vma x
Control 62 + 14 7.9 +_ 0.6 30 + 5 3.2 _+ 0.4 13.7 _+ 0.3 6.6 -+ 0.4 
250pM DODG 15 + 1 6.4 + 0.2 23 + 6 3.8 -+ 0.6 15 + 4 7 + 2 
Insulin receptor autophosphorylation was measured inthe presence ofTriton X-100 mixed micelles (0.1%) with or without 250 pM 1,2-dioleoyl-sn- 
glycerol. Kinetic parameters for insulin were determined in the presence of50 pM ATE Kinetic parameters for ATP were determined in the presence 
of sub-saturating (10 nM) or saturating (700 nM) insulin concentrations. Autophosphorylation was measured as described inthe legend of Fig. 1. 
crease in affinity of the receptor for insulin is that diacylglycerol 
increases the partitioning of insulin into micelles. However, two 
results indicate that insulin-binding is not regulated by surface- 
partitioning. First, the measured ECs0 is similar to the Ko for 
binding of insulin to NIH 3T3 HIR3.5 cells (1 nM for 38% of 
the receptor population and 100 nM for 63% of the receptor 
population [19]). Thus, the affinity for insulin is the same in 
detergent micelles or in the native plasma membrane. Second, 
the ECs0 for insulin measured above was independent of deter- 
gent concentration (data not shown), indicating that partition- 
ing into micelles (which would increase with increasing deter- 
gent) is unlikely to affect the accessibility of insulin to the 
insulin receptor. 
Diacylglycerol-mediated stimulation was relatively insensi- 
tive to micelle structure as assessed by two criteria. First, inclu- 
sion of 6 mol% phosphatidylcholine, phosphatidylethanolam- 
ine, sphingomyelin, phosphatidylglycerol, phosphatidylinosi- 
tol, phosphatidylserine, phosphatidic acid, or sphingosine had 
no effect on the stimulation mediated by 6 mol% diacylglycerol 
(not shown). Thus, increasing micelle size or charge did not 
affect he ability of diacylglycerol to increase the insulin recep- 
tot's affinity for insulin. Second, the concentration of dia- 
cylglycerol mediating half-maximal stimulation was the same 
at 13.5°C and 21°C, even though micelles are significantly 
smaller at the lower temperature [24]. 
Although diacylglycerol had no effect on the catalytic activ- 
ity of the insulin receptor, this lipid increased by approximately 
20% the maximal amount of tyrosine phosphorylation f the 
receptor (Fig. 2, triangles) relative to controls (Fig. 2, circles). 
Thus, the lipid may be unmasking a phosphorylation site or 
unmasking a population of receptor. 
Additional experiments revealed that the stimulation by dia- 
cylglycerol decreased with decreasing hydrophobicity: for ex- 
ample, the receptor was half-maximally stimulated by 250 pM 
dioctanoylglycerol (not shown) compared with 100 pM di- 
oleoylglycerol. The hydroxyl group tethered to a hydrophobic 
moiety was insufficient for activation: oleyl alcohol had no 
significant effect on the receptor (not shown). Rather, stimula- 
tion required two acyl chains on the glycerol backbone: mono- 
oleoylglycerol (up to 500 pM) did not affect the activity of the 
insulin receptor (not shown). Thus, activation required the 
glycerol backbone and two acyl chains, with increasing hydro- 
phobicity resulting in greater stimulation. 
3.3. Diacylglycerol-mediated stimulation of the insulin receptor 
is independent of protein kinase C 
One explanation for the diacylglycerol-mediated stimulation 
of the insulin receptor isthat diacylglycerol modulates the func- 
tion of another protein that regulates the insulin receptor. A 
protein that depends on diacylglycerol for activity [5] and 
whose activation affects the insulin receptor [25-27] is protein 
kinase C. 
Four results revealed that the activation of the insulin recep- 
tor was independent of protein kinase C. First, phorbol myris- 
tare acetate, a potent activator of protein kinase C that substi- 
tutes for diacylglycerol [28], had no significant effect on the 
autophosphorylation of the insulin receptor (Fig. 2, squares). 
Second, the activation of the insulin receptor by diacylglycerol 
was not stereospecific; the enantiomer 2,3-diacyl-sn-glycerol 
and structural isomer 1,3 diacylglycerol activated the insulin 
receptor equally well (Fig. 3A). In marked contrast, activation 
of protein kinase C is specific for 1,2-diacyl-sn-glycerol (Fig. 
3B) [29 32]. Third, Western blot analysis of samples revealed 
no detectable conventional isozymes of protein kinase C (not 
shown). Lastly, no protein kinase C activity towards asynthetic 
substrate was detected under the conditions of the assays. Thus, 
the stimulation of the insulin receptor by diacylglycerol was 
independent of protein kinase C. 
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Fig. 2. Phorbol myristate acetate does not affect insulin receptor auto- 
phosphorylation. Time course of autophosphorylation of the insulin 
receptor was performed in the absence (closed symbols) or presence 
(open symbols) of 10 nM insulin and in the presence of 0.1% Triton 
X-100 micelles (o,o), or 0.1% Triton X-100 mixed micelles containing 
100 pM dioleoylglycerol (A,A) or 200 nM phorbol myristate acetate 
(D j ) .  Incorporation of phosphate onto tyrosine residues of the fl sub- 
unit was determined asdescribed in the legend of Fig. 1. 
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Fig. 3. Stimulation of insulin receptor autophosphorylation by diacylglycerol is not stereospecific. (A) Insulin receptor autophosphorylation was 
measured in the presence of 0.1% Triton X-100 mixed micelles containing increasing concentrations (0-500 ktM) of 1,2-dioleoyl-sn-glycerol (o,e), 
1,3-dioleoyl-sn-glycerol (A j,) or 2,3-dioleoyl-sn-glycerol ([],=); assays included no insulin (closed symbols) or 10 nM insulin (open symbols). Other 
conditions are as described in the legend of Fig. 1. Error bars represent the standard error of the mean of three sets of data. (B) Phosphorylation 
of a peptide substrate by protein kinase C was measured inthe presence of 1.2 mM Ca 2+ and Triton X-100 mixed micelles containing 15 mol% PS 
and either 5 mol% 1,2-dioleoyl-sn-glycerol (DODG), 5 mol% 1,3-dioleoyl-sn-glycerol, 5 mol% 2,3-dioleoyl-sn-glycerol, o  no diacylglycerol. One 
sample was measured in the absence of lipid and Ca 2+. 
Grunberger and coworkers have also reported that dia- 
cylglycerol stimulates the tyrosine kinase activity of insulin 
receptor in human mononuclear cells [33]. However, in contrast 
to our findings, they reported that diacylglycerol stimulates the 
insulin receptor in the absence of insulin. The indirect involve- 
ment of protein kinase C in the mononuclear cell study may 
account for the difference. Indeed, earlier work by this group 
showed that treatment ofhuman mononuclear cells by phorbol 
esters or diacylglycerols stereospecifically inhibited binding of 
insulin to the receptor; isomers that do not activate protein 
kinase C had no effect on insulin-binding [34]. 
3.4. Conclusions 
The foregoing results reveal that diacylglycerol increases the 
tyrosine kinase activity of the insulin receptor by increasing its 
affinity for insulin. This stimulation is independent of protein 
kinase C and is likely mediated by a direct interaction of the 
lipid with the receptor: qualitatively similar data were obtained 
with receptor from two sources (NIH 3T3 HIR 3.5 cells and rat 
liver), either in crude extracts or partially purified. 
Several mechanisms could account for the diacylglycerol- 
mediated stimulation of the insulin receptor. For example, dia- 
cylglycerol could alter the structure of lipids surrounding the 
insulin receptor thus affecting receptor function. The effect of 
diacylglycerol n the stability and structure of membranes is 
well-documented [35,36]. Most notably, high concentrations 
(>30 mol%) induce the formation of a nonlamellar phase 
[36]. For example, activation of phospholipase A 2 by dia- 
cylglycerol has been attributed to structural perturbations 
caused by this lipid [8,37 39]. With regards to the insulin recep- 
tor, compounds that alter membrane physical properties have 
been shown recently to affect the autophosphorylation of the 
insulin receptor in intact cells [40]. Although stimulation of the 
insulin receptor by diacylglycerol may result from structural 
perturbations induced by this lipid, it is noteworthy that dia- 
cylglycerol stimulated the insulin receptor in detergent:lipid 
mixed micelles, indicating that a specific membrane structure 
was not necessary for the stimulation. Furthermore, stimula- 
tion was relatively insensitive to micelle size (varied with tem- 
perature and added phospholipids) or charge. 
A second possibility is that diacylglycerol interacts directly 
with the receptor, acting as an allosteric activator. Precedent 
for such an interaction exists in the specific binding of dia- 
cylglycerol to protein kinase C. This binding promotes a high 
affinity interaction with phosphatidylserine that results in an 
alteration i  the structure of the enzyme [5]. The lack of stereo- 
specificity in the interaction of the insulin receptor with dia- 
cylglycerol argues against the existence of a specific diacylglyc- 
erol binding site. Nonetheless, the requirement for two rela- 
tively hydrophobic acyl chains uggests that diacylglycerol may 
bind to the insulin receptor via a hydrophobic nteraction. Such 
an interaction could increase the receptor's affinity for insulin 
by stabilizing the active conformation. Steric constraints may 
prevent other lipids, with much larger polar headgroups, from 
close apposition with the receptor. 
The insulin-induced generation of diacylglycerol in the 
plasma membrane indicates that this second messenger may be 
a direct modulator of the receptor [12 14]. Because levels of 
insulin in the blood plasma (approximately 0.1 nM [41]) are well 
below the K d for the insulin: receptor interaction, diacylglycerol 
would have a significant effect on insulin receptor activity 
under physiological conditions. 
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